Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 0.36% today. In the last week its performance is 1.29%, and 8.08% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 70.61, so today’s gain of 0.36% is a significant step towards its target price. The GAP today is therefore -0.13%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 109396.3, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 70.20%.
At the current price of 67.19, it has a dividend yield of 3.41%, and its target price is 70.61. This is with a profit margin of 23.10%, and total debt/equity of *TBA. AbbVie Inc. (NYSE:ABBV) has a P/E of 19.19, as well as a forward P/E of 11.82.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 18.08%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.28%.
Performance for the year is 1.15%. Since its IPO date on 1/2/2013, the total performance to date is 16.31%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 5206399, while its average volume is 8515.29. Whilst the total gain today was 0.36%, it did have a day high of -0.09%.
Volatility for this week has been at 1.08%, and 1.29% for the month. The 52-week low for AbbVie Inc., ABBV has been 52.14%, while the 52-week-high has reached -0.09%.
Looking at its return of investments, which is 16.90%, and its return on assets is *TBA. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.18, and the P/S is 4.42, along with a P/B of 23.32. Meanwhile it has a p/cash of *TBA.